Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study

C. Domingo Ribas, K.F. Rabe, A. Menzies-Gow, D. Price, G. Brusselle, M.E. Wechsler, C. Xia, M. Djandji, R. Gall, J.A. Jacob-Nara, P.J. Rowe, Y. Deniz, S. Siddiqui

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Article numberA2365
Number of pages2
JournalAmerican journal of respiratory and critical care medicine
Publication statusPublished - 1 May 2022
EventATS 2022 - United states , San Francisco, United States
Duration: 13 May 202218 May 2022

Cite this